enoxacin has been researched along with Sarcoma, Ewing in 2 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JA | 1 |
| Crawford, KA | 1 |
| Spada, PA | 1 |
| Martin, LR | 1 |
| Zhang, J | 1 |
| Wong, R | 1 |
| Reid, JM | 1 |
| Stewart, CF | 1 |
| Frank, TM | 1 |
| Liu, Q | 1 |
| Michalek, JE | 1 |
| Keller, C | 1 |
| Cornaz-Buros, S | 1 |
| Riggi, N | 1 |
| DeVito, C | 1 |
| Sarre, A | 1 |
| Letovanec, I | 1 |
| Provero, P | 1 |
| Stamenkovic, I | 1 |
2 other studies available for enoxacin and Sarcoma, Ewing
| Article | Year |
|---|---|
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Benzamides; Disease Models, Animal; Enoxac | 2023 |
Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma.
Topics: AC133 Antigen; Animals; Antigens, CD; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Enoxacin; Glyco | 2014 |